Stryker Co. (NYSE:SYK) Shares Sold by Values Added Financial LLC

Values Added Financial LLC reduced its position in Stryker Co. (NYSE:SYK) by 11.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,553 shares of the medical technology company’s stock after selling 202 shares during the quarter. Values Added Financial LLC’s holdings in Stryker were worth $465,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. Quarry LP acquired a new stake in Stryker in the 1st quarter valued at about $27,000. Freedom Wealth Alliance LLC acquired a new stake in Stryker in the 4th quarter valued at about $26,000. Rise Advisors LLC grew its stake in Stryker by 692.9% in the 3rd quarter. Rise Advisors LLC now owns 111 shares of the medical technology company’s stock valued at $30,000 after acquiring an additional 97 shares during the last quarter. West Tower Group LLC acquired a new stake in Stryker in the 2nd quarter valued at about $35,000. Finally, Cornerstone Planning Group LLC acquired a new stake in Stryker in the 2nd quarter valued at about $38,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Stryker

In other Stryker news, Director Allan C. Golston sold 3,273 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $341.00, for a total value of $1,116,093.00. Following the completion of the sale, the director now owns 14,242 shares of the company’s stock, valued at $4,856,522. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Allan C. Golston sold 3,273 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $341.00, for a total transaction of $1,116,093.00. Following the completion of the sale, the director now owns 14,242 shares of the company’s stock, valued at $4,856,522. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronda E. Stryker sold 201,146 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the sale, the director now directly owns 3,755,128 shares of the company’s stock, valued at approximately $1,287,633,391.20. The disclosure for this sale can be found here. Insiders sold 212,109 shares of company stock valued at $72,845,768 over the last 90 days. 5.90% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on SYK shares. Truist Financial upped their target price on shares of Stryker from $330.00 to $345.00 and gave the company a “hold” rating in a report on Wednesday, January 31st. Citigroup upped their target price on shares of Stryker from $340.00 to $362.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Wells Fargo & Company upped their target price on shares of Stryker from $336.00 to $364.00 and gave the company an “overweight” rating in a report on Wednesday, January 31st. Royal Bank of Canada restated an “outperform” rating and issued a $360.00 target price on shares of Stryker in a report on Thursday, February 15th. Finally, Morgan Stanley upped their target price on shares of Stryker from $300.00 to $320.00 and gave the company an “equal weight” rating in a report on Monday, December 4th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $331.52.

Stryker Stock Down 0.2 %

SYK opened at $357.87 on Friday. The firm has a 50 day moving average price of $343.42 and a 200 day moving average price of $305.60. The company has a market cap of $136.16 billion, a PE ratio of 43.38, a price-to-earnings-growth ratio of 2.92 and a beta of 0.89. Stryker Co. has a 1 year low of $249.98 and a 1 year high of $361.41. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.97 and a current ratio of 1.58.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.27 by $0.19. Stryker had a net margin of 15.44% and a return on equity of 22.99%. The firm had revenue of $5.82 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the prior year, the company earned $3.00 EPS. The company’s revenue was up 11.8% on a year-over-year basis. Sell-side analysts expect that Stryker Co. will post 11.86 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Friday, March 29th will be given a $0.80 dividend. This represents a $3.20 annualized dividend and a yield of 0.89%. The ex-dividend date is Wednesday, March 27th. Stryker’s dividend payout ratio (DPR) is 38.79%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.